Skip to content
naulon
Not checkedNot checked for notices yet.

Focal Hematopoietic Hyperplasia of Rib: A Rare Pseudotumor and Review of Literature

Maneesh Vijay, Asit Ranjan Mridha, Ruma Ray and 3 more

Journal of Pathology and Translational Medicine · 2015

doi:10.4132/jptm.2013.10.02 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Primary tumors of the rib are uncommon, comprising 5%– 10% of all bony tumors. Benign tumors constitute 63% of this group [1]. Common benign entities include osteochondroma, enchondroma, and fibrous dysplasia, while common malignant tumors of the ribs include plasmacytoma, chondrosarcoma, osteosarcoma, and Ewing’s sarcoma [1]. Focal hematopoietic hyperplasia (FHH) is an unusual benign lesion characterized by an expansive osteolytic mass involving the rib in all reported cases [2-4]. Most cases were detected incidentally on routine chest radiography performed for unrelated reasons. The lesion is typically composed of hypercellular marrow containing all three lineages of hematopoietic cells with interspersed fatty marrow; no hematopoietic dyspoiesis or malignancy is seen. Though clinical signs and radiological features of the lesion often simulate a true neoplasm, in reality it is a pseudotumor. Follow-up investigation has failed to show any recurrence or neoplastic transformation after resection of the lesion [2]. To the best of our knowledge, to date only four cases have been reported in the English literature [2-4]. We report a case of FHH in the right second rib in a 26-year-old female who underwent surgery after radiological diagnosis of osteochondroma.

Abstract licence: CC BY-NC

References8

    8 more references, whose wording the paper’s licence keeps private.

    Reads

    Read by people on this page

    None yet.

    Checked or read by AI through naulon

    None yet.

    A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

    Are you an author?

    Is this your paper?

    Claim it to add your note and be paid when agents cite it. Free.